Source:http://linkedlifedata.com/resource/pubmed/id/17635045
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-7-19
|
pubmed:abstractText |
Umbilical cord blood (UCB) is an easily accessible alternative source for multipotent mesenchymal stromal cells (MSCs) and is generally believed to provide MSCs with a higher proliferative potential compared with adult bone marrow. Limitations in cell number and strict dependence of expansion procedures from selected lots of fetal bovine serum have hampered the progress of clinical applications with UCB-derived MSCs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1746-076X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
371-82
|
pubmed:meshHeading | |
pubmed:year |
2007
|
pubmed:articleTitle |
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
|
pubmed:affiliation |
Medical University, Department of Internal Medicine, Division of Hematology and Stem Cell Transplantation, Auenbrugger Pl. 38, A-8036, Graz, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|